Page 87 - 南京医科大学自然版
P. 87

第45卷第8期       孙王妍,陈伟观,周三连,等. 血清PDCD4水平对急性缺血性脑卒中患者神经功能缺损和预后的
                  2025年8月               预测价值[J]. 南京医科大学学报(自然科学版),2025,45(8):1140-1147                   ·1143 ·


                                    表1 轻度神经功能缺损和中重度神经功能缺损的AIS患者基线特征比较
                Table 1  Comparison of baseline characteristics of AIS patients with mild neurological deficits and moderate to severe neuro-
                       logical deficits

                                                                   Patients with AIS
                             Variable            Mild neurological deficits  Moderate to severe neurological deficits  t/Z/χ 2  P
                                                       (n=70)                   (n=40)
                 Demographic data
                   Age[years,M(P25,P75)]             70(62.50,77.50)         75.50(71.50,84)0       -2.24  0. 025
                   Male[n(%)]                        46(65.70)00000            12(40.00)0            5.70  0.017
                 Risk factors
                   Diabetes[n(%)]                    17(24.30)00000             9(30.00)             0.36  0.549
                   Hypertension[n(%)]                42(60.00)0 000.           18(60.00)             0.57  0.450
                   Heart rate[beats/min,M(P25,P75)]  78.00(69.00,84.50)00   075.00(64.75,82.50)     -0.88  0.379
                   DNT[min,M(P25,P75)]            36.00(28.50,47.00)00     0.39.50(22.75,54.25)     -0.66  0.509
                   SBP(mmHg,x ± s)                   149.26 ± 20.40           155.20 ± 16.73        -1.41  0.159
                   DBP(mmHg,x ± s)                   083.80 ± 12.19           082.80 ± 12.58         0.37  0.711
                   Atrial fibrillation[n(%)]         13(18.60)00000            12(40.00)0            5.14  0.023
                   Smoking history[n(%)]             22(31.40)00000             5(16.70)             2.32  0.127
                   Alcohol[n(%)]                     11(15.70)00000             5(16.70)             0.01  0.920
                 Laboratory data
                   Neutrophil count[×10 /L,M(P25,P75)]  3.90(3.20,5.75)000  0.7.60(5.38,10.23)      -4.47  <0.001
                                   9
                   Lymphocyte count[×10 /L,M(P25,P75)]  1.60(1.20,2.05)000   .0.85(0.68,1.15)       -5.00  <0.001
                                    9
                   NLR[M(P25,P75)]                 2.75(1.86,3.71)000       0.8.79(4.63,15.61)      -5.72  <0.001
                   PLT[×10 /L,M(P25,P75)]        172.00(139.50,223.50)    00 166.00(137.75,209.00)  -0.58  0.560
                          9
                   PDW[%,M(P25,P75)]              13.70(11.60,16.15)00     0.14.50(12.60,17.15)     -1.30  0.194
                   PCT[ng/mL,M(P25,P75)]           0.03(0.02,0.05)000        .0.06(0.02,0.18)       -2.70  0.007
                   Cr[μmol/L,M(P25,P75)]          65.00(56.50,80)00.00     0.67.50(58.50,80.25)     -0.46  0.646
                   UA[μmol/L,M(P25,P75)]            310(259,371)000.      00.263.50(197.50,298.00)  -2.54  0.011
                   BUN[mg/dL,M(P25,P75)]           5.15(4.53,6.36)000        .5.93(4.72,7.59)       -1.80  0.072
                   Hs⁃CRP[mg/L,M(P25,P75)]         0.91(0.14,5.80)000       .21.93(0.49,49.54)      -3.20  0.001
                   D⁃dimer[ng/mL,M(P25,P75)]        700(455,1 290)00.      0.3 340(1 158,5 415)     -4.98  <0.001
                   FIB[g/L,M(P25,P75)]             2.32(1.84,2.71)000        .2.71(2.24,3.95)       -2.38  0.017
                   FDP[mg/L,M(P25,P75)]            1.87(0.91,5.32)000       .10.70(5.74,18.72)      -4.99  <0.001
                   TG[mmol/L,M(P25,P75)]           1.46(0.91,1.89)000         1.27(1.00,1.90)       -0.44  0.660
                   CHO[mmol/L,M(P25,P75)]          4.30(3.44,4.96)000        .4.09(3.52,4.70)       -0.64  0.522
                   APTT(s,x ± s)                      28.17 ± 3.51             27.28 ± 2.63          1.25  0.211
                   FBG[ mmol/L,M(P25,P75)]         5.08(4.55,6.17)000        .6.20(5.37,8.75)       -3.60  <0.001
                   HbA1c[ mmol/L,M(P25,P75)]       5.90(5.60,6.40)000        .6.15(5.70,7.30)       -1.56  0.119
                   LDL⁃C( mmol/L,x ± s)               02.82 ± 1.03             02.60 ± 0.92          1.00  0.318
                   Serum PDCD4[ng/mL,M(P25,P75)]   1.88(1.20,2.87)000        .3.76(2.39,7.15)       -4.98  <0.001
                   NLR:neutrophil⁃to⁃lymphocyte ratio;Hs⁃CRP:high⁃sensitivity C⁃reactive protein;PCT:procalcitonin;PLT:platelet;PDW:platelet distribution
                width;BUN:blood urea nitrogen;Cr:creatinine;UA:uric acid;FIB:fibrinogen;FDP:fibrin degradation product;TG:triglycerides;CHO:cholesterol;
                APTT:activated partial thromboplastin time;FBG:fasting blood glucose;HbA1c:hemoglobin A1c;LDL⁃C:low⁃density lipoprotein cholesterol.

                                                                  影响 AIS 神经功能缺损和不良预后的主要驱动因
                3  讨 论
                                                                  素 [20] 。课题组前期基础研究报道脂多糖刺激促进
                    炎症是脑血管疾病尤其是缺血性脑卒中病理                           小胶质细胞内 PDCD4 表达增加,敲低 PDCD4 抑制
                生理的重要环节。研究报道脑卒中后神经炎症是                             小胶质细胞分泌炎症因子进而促进神经元存活,且
   82   83   84   85   86   87   88   89   90   91   92